Indole compound
AssigneeTakeda Pharmaceutical Company Limited
InventorsTsuneo Yasuma, Osamu Ujikawa, Masahiro Itoh, Kazuko Aoki
Life of this patent
Estimating the term…
Abstract
The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I): wherein R1 is a hydrogen atom or a halogen atom; R2 is a group represented by wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.
Claims1
2-{2-[7-[Methyl(2-thienylsulfonyl)amino]-5-(trifluoromethoxy)-1H-indol-2-yl]-4,5-dihydro-1,3-thiazol-5-yl}acetamide or a salt thereof.
Dependencies are inferred from the claim text.